Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs ALEMBIC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA ALEMBIC ASTRAZENECA PHARMA/
ALEMBIC
 
P/E (TTM) x 91.1 25.3 360.7% View Chart
P/BV x 16.5 0.7 2,204.3% View Chart
Dividend Yield % 0.3 2.5 12.0%  

Financials

 ASTRAZENECA PHARMA   ALEMBIC
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-22
ALEMBIC
Mar-22
ASTRAZENECA PHARMA/
ALEMBIC
5-Yr Chart
Click to enlarge
High Rs4,580143 3,196.1%   
Low Rs2,52972 3,512.5%   
Sales per share (Unadj.) Rs322.23.0 10,578.7%  
Earnings per share (Unadj.) Rs24.63.4 734.0%  
Cash flow per share (Unadj.) Rs31.43.5 886.0%  
Dividends per share (Unadj.) Rs10.001.80 555.6%  
Avg Dividend yield %0.31.7 16.8%  
Book value per share (Unadj.) Rs203.897.2 209.6%  
Shares outstanding (eoy) m25.00256.78 9.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x11.035.3 31.2%   
Avg P/E ratio x144.332.1 449.8%  
P/CF ratio (eoy) x113.130.4 372.7%  
Price / Book Value ratio x17.41.1 1,575.4%  
Dividend payout %40.653.6 75.7%   
Avg Mkt Cap Rs m88,86327,643 321.5%   
No. of employees `000NANA-   
Total wages/salary Rs m2,302215 1,072.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m8,056782 1,029.9%  
Other income Rs m148892 16.6%   
Total revenues Rs m8,2041,674 490.1%   
Gross profit Rs m862139 618.7%  
Depreciation Rs m17049 348.6%   
Interest Rs m104 244.2%   
Profit before tax Rs m830979 84.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m214117 183.8%   
Profit after tax Rs m616862 71.5%  
Gross profit margin %10.717.8 60.1%  
Effective tax rate %25.811.9 216.6%   
Net profit margin %7.6110.2 6.9%  
BALANCE SHEET DATA
Current assets Rs m7,6531,433 534.0%   
Current liabilities Rs m3,923678 578.9%   
Net working cap to sales %46.396.6 47.9%  
Current ratio x2.02.1 92.2%  
Inventory Days Days6110,346 0.6%  
Debtors Days Days39710 5.5%  
Net fixed assets Rs m2,12024,886 8.5%   
Share capital Rs m50514 9.7%   
"Free" reserves Rs m5,04424,452 20.6%   
Net worth Rs m5,09424,966 20.4%   
Long term debt Rs m00-   
Total assets Rs m9,77326,320 37.1%  
Interest coverage x88.4252.6 35.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80 2,773.7%   
Return on assets %6.43.3 194.6%  
Return on equity %12.13.5 350.2%  
Return on capital %16.53.9 419.0%  
Exports to sales %02.0 0.0%   
Imports to sales %31.70.3 10,925.1%   
Exports (fob) Rs mNA16 0.0%   
Imports (cif) Rs m2,5522 112,422.9%   
Fx inflow Rs m44216 2,840.6%   
Fx outflow Rs m2,5522 112,422.9%   
Net fx Rs m-2,11013 -15,864.7%   
CASH FLOW
From Operations Rs m1,008-177 -568.0%  
From Investments Rs m47188 25.1%  
From Financial Activity Rs m-95-58 162.6%  
Net Cashflow Rs m961-47 -2,037.3%  

Share Holding

Indian Promoters % 0.0 70.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 5.0 77.0%  
FIIs % 2.5 0.8 300.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 29.1 85.9%  
Shareholders   49,085 83,612 58.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs ALEMBIC

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs ALEMBIC Share Price Performance

Period ASTRAZENECA PHARMA ALEMBIC S&P BSE HEALTHCARE
1-Day -0.02% -0.27% 0.23%
1-Month 2.02% 2.40% 0.36%
1-Year 3.02% -27.39% -6.87%
3-Year CAGR 7.94% 11.12% 20.16%
5-Year CAGR 24.01% 12.07% 11.07%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the ALEMBIC share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of ALEMBIC the stake stands at 70.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of ALEMBIC.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 40.6%.

ALEMBIC paid Rs 1.8, and its dividend payout ratio stood at 53.6%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of ALEMBIC.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Mark Mobius on Cryptos | Dharmaj Crop IPO Fully Subscribed on Debut | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets hit new records following heavy gains from Reliance and other oil marketing companies as crude prices fell.